Hemp-derived cannabinoids–particularly intoxicating hemp-derived cannabinoids have proliferated in the marketplace in the wake of the 2018 Farm Bill.
Some prognosticators have taken the position that Congress federally legalized cannabis back in 2018. This proliferation of products has put the marijuana and hemp industries at odds.
We will first break down the background of the 2018 Farm Bill regarding hemp-derived cannabinoids with a discussion on recent market trends. Next, we will examine state legislative responses to regulate or prohibit intoxicating hemp-derived cannabinoids with a summary of select litigation playing out around the country. Finally, we will conclude with some predictions and observations of the future of the Farm Bill and what changes may take place this fall.
John Fraser: Michigan Team Leader of Dykema’s Cannabis Practice
As the Michigan Team Leader of Dykema’s Cannabis Practice, John often serves as the legal “quarterback” for a cannabis business’s myriad of issues as part of a multidisciplinary legal team. Whether it’s providing rapid feedback on an emerging legal issue or negotiating a multi-million dollar cannabis brand licensing agreement, John provides effective leadership and counsel so that clients can conduct their business effectively, efficiently, and—most importantly—in compliance with applicable laws.
Lance Boldrey : National leader of the Cannabis Industry Group at Dykema
Lance Boldrey is a member and the national leader of the Cannabis Industry Group at Dykema, guiding clients through the evolving legal and regulatory landscape of the cannabis industry. His practice covers licensing, compliance, legislative matters, and government relations, representing clients ranging from small retailers to large vertically integrated companies, as well as lenders and investors. Lance also coordinates Dykema’s work on real estate, corporate transactions, M&A, and other legal needs critical to the industry’s growth.